Image

Adult and Juvenile Myositis

Recruiting
2 - 100 years of age
Both
Phase N/A

Powered by AI

Overview

This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems associated with them. Myositis is an inflammatory muscle disease that can damage muscles and other organs, resulting in significant disability.

Children or adults with polymyositis or dermatomyositis or a related condition may be evaluated under this study. Healthy children or adults will also be enrolled as "controls," for comparison of test results.

All patients will undergo a complete history (including completing some questionnaires) and physical examination, review of medical records, and blood and urine tests. Patients may then choose to participate in an additional 1- to 5-day evaluation, which will include some or all of the following diagnostic, treatment or research procedures:

  1. Standardized muscle strength testing, range of motion of joints and walking (gait) analysis by a physiotherapist; completion of a questionnaire regarding ability to perform daily tasks
  2. Skin assessment, possibly including photographs of lesions and a skin biopsy (removal of a small skin sample under local anesthetic)
  3. Magnetic resonance imaging (scans that use magnetic fields to visualize tissues) of leg muscles
  4. Swallowing studies, including a physical examination and questionnaire on swallowing ability, studies of tongue strength, and ultrasound imaging during swallowing, and possibly, a modified barium swallow
  5. Voice and speech assessment, possibly including computerized voice analysis and laryngoscopy-analysis of the larynx (voice box) using a small rigid scope with a camera placed in the mouth to view and record vocal cord function
  6. Pulmonary function tests (measurement of air moved into and out of the lungs, using a breathing machine) to evaluate lung function and, possibly, chest X-ray
  7. Electrocardiogram (measurement of the electrical activity of the heart) and, possibly, echocardiogram (ultrasound imaging of the heart)
  8. Endocrine evaluation
  9. Eye examination, in patients with vision loss or other eye symptoms
  10. Nutrition assessment to evaluate muscle mass and muscle wasting, including tape measurements or bioelectric impedance testing, a painless procedure in which wires are attached to the extremities with a sticky paste.
  11. Muscle ultrasound.
  12. Electromyography (record of the electrical activity of muscles)
  13. Muscle or skin biopsy (removal of a small piece of muscle tissue for microscopic examination)

All patients may have only a one-time evaluation or may return for one follow-up evaluations (either the 1-day or 3- to 5-day evaluation) over a 1-year period.

Healthy children will undergo a medical history and brief physical examination; blood and urine tests; speech and swallowing studies including questionnaires and physical examination, tongue strength, and ultrasound study; and bioelectric impedance testing. Children 8 to 18 years old may also have exercise testing.

Description

This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems associated with them. Myositis is an inflammatory muscle disease that can damage muscles and other organs, resulting in significant disability.

Children or adults with polymyositis or dermatomyositis or a related condition may be evaluated under this study. Healthy children or adults will also be enrolled as "controls," for comparison of test results.

All patients will undergo a complete history (including completing some questionnaires) and physical examination, review of medical records, and blood and urine tests. Patients may then choose to participate in an additional 1- to 5-day evaluation, which will include some or all of the following diagnostic, treatment or research procedures:

  1. Standardized muscle strength testing, range of motion of joints and walking (gait) analysis by a physiotherapist; completion of a questionnaire regarding ability to perform daily tasks
  2. Skin assessment, possibly including photographs of lesions and a skin biopsy (removal of a small skin sample under local anesthetic)
  3. Magnetic resonance imaging (scans that use magnetic fields to visualize tissues) of leg muscles
  4. Swallowing studies, including a physical examination and questionnaire on swallowing ability, studies of tongue strength, and ultrasound imaging during swallowing, and possibly, a modified barium swallow
  5. Voice and speech assessment, possibly including computerized voice analysis and laryngoscopy-analysis of the larynx (voice box) using a small rigid scope with a camera placed in the mouth to view and record vocal cord function
  6. Pulmonary function tests (measurement of air moved into and out of the lungs, using a breathing machine) to evaluate lung function and, possibly, chest X-ray
  7. Electrocardiogram (measurement of the electrical activity of the heart) and, possibly, echocardiogram (ultrasound imaging of the heart)
  8. Endocrine evaluation
  9. Eye examination, in patients with vision loss or other eye symptoms
  10. Nutrition assessment to evaluate muscle mass and muscle wasting, including tape measurements or bioelectric impedance testing, a painless procedure in which wires are attached to the extremities with a sticky paste.
  11. Muscle ultrasound.
  12. Electromyography (record of the electrical activity of muscles)
  13. Muscle or skin biopsy (removal of a small piece of muscle tissue for microscopic examination)

All patients may have only a one-time evaluation or may return for one follow-up evaluations (either the 1-day or 3- to 5-day evaluation) over a 1-year period.

Healthy children will undergo a medical history and brief physical examination; blood and urine tests; speech and swallowing studies including questionnaires and physical examination, tongue strength, and ultrasound study; and bioelectric impedance testing. Children 8 to 18 years old may also have exercise testing.

Eligibility

  • ELIGIBILITY CRITERIA:

Patients with Myositis:

Inclusion Criteria:

All patients should have age range 2- 100 years.

        All Patients admitted to the study must satisfy at least one of the following criteria
        among item 1 (A or B or C) OR item 2 (A or B or C) AND item 3:
          1. Patient has documented evidence that he/she meets criteria for an idiopathic
             inflammatory myopathy
             A. Possible, probable or definite adult or juvenile polymyositis or dermatomyositis by
             Bohan and Peter criteria
             B. Possible, probable or definite inclusion body myositis by Griggs and/or ENMC
             criteria
             C. Has an idiopathic inflammatory myopathy that does not meet these criteria,
             including common or rarer forms of myositis such as cancer- associated, focal,
             orbital, eosinophilic myositis, macrophagic, proliferative, etc.
          2. Has one of the following conditions:
        2A. Have a disorder that is related to an idiopathic inflammatory myopathy, that may
        include:
          -  Inflammatory and non-inflammatory myopathies:
          -  Mimicking and related skin disorders:
          -  Disorders of the complications of myositis (including interstitial lung disease,
             calcifying disorders, cardiomyopathies, etc.):
          -  Overlapping autoimmune diseases that may be associated with myositis
          -  Patients with muscle and/or skin inflammation and documented environmental exposures:
          -  Patients with myositis or complications of myositis and suspected genetic disorders:
          -  Patients with undifferentiated connective tissue disease
          -  Patients with signs or symptoms of myositis (such as weakness, skin rashes,
             interstitial lung disease) or laboratory abnormalities (such as elevated CK or muscle
             biopsy with myopathic features) who do not have an established diagnosis of myositis
             for them to be evaluated to establish a diagnosis
             3. Ability of patient or parent/guardian to give informed consent to all or part of
             the study after full information has been provided.
        Exclusion Criteria:
          1. Patients <2 years or >100 years will be excluded.
          2. Any conditions in which the drawing of the amount of blood required or undergoing
             procedures needed for the study is not deemed medically appropriate by the treating
             physician or the principal investigator.]
        For females of childbearing potential who are pregnant, they will be permitted to enroll,
        but would be excluded from radiographic procedures involving radiation or greater than
        minimal risk procedures, including obtaining biopsies.
        Relatives of Patients with Myositis:
        For patients with at least one first-degree relative affected with IIIM, all available
        first-degree relatives (affected and unaffected) are eligible to participate in the
        genetics portion of the protocol. For patients in which two or more first degree relatives
        are affected with myositis, any available close relatives (affected or unaffected parents,
        siblings or children, as well as grandparents and grandchildren, or other close relatives,
        when available) are eligible to participate in the genetics portion of the protocol.
        Inclusion criteria:
          1. First or more distant relative of a proband with myositis, for genetics studies.
          2. Ability of patient or parent/guardian to give informed consent to all or part of the
             study after full information has been provided.
        Exclusion Criteria:
          1. Patients <2 years or >100 years will be excluded.
          2. Any conditions in which the drawing of the amount of blood required or undergoing
             procedures needed for the study is not deemed medically appropriate by the treating
             physician or the principal investigator.
          3. Pregnancy (females of childbearing potential). Verbal confirmation they are not
             pregnant.
        Healthy Volunteers:
        Inclusion Criteria:
          1. Healthy volunteer subjects for biomarker studies will be gender and age-matched
             (within 5 years) with a myositis patient, as reasonably close as possible.
          2. Volunteer is not related to a myositis patient who is enrolled in the study
          3. Volunteer is in good health, without a recognized systemic rheumatic disorder,
             autoimmune disease, immune medicated disease, or cancer, and is not taking any
             anti-inflammatory medicines, including nonsteroidal anti-inflammatory drugs (NSAIDS)
             or corticosteroids
          4. Volunteer or volunteer s parent/guardian could give assent/informed consent to all or
             part of the study after full information has been provided
        Exclusion Criteria:
        If Any Yes answer patient is not eligible for study
          1. Volunteer has undergone surgery or had a major trauma within the past 2 months
          2. Volunteer used anti-inflammatory medications within the past 8 weeks of enrollment,
             including not currently receiving nonsteroidal anti-inflammatory drugs or
             corticosteroids
          3. Volunteer has been diagnosed with a chronic infectious illness, inflammatory disease,
             malignancy, cardiac or pulmonary disease, muscle disorder, clotting disorder,
             metabolic disorder, systemic rheumatic or autoimmune disease, or immune-mediated
             disease
          4. Volunteer is pregnant (verbally screened for females of childbearing potential)
          5. Volunteer has a medical illness that in the judgement of the investigators does not
             allow safe blood draws or other clinical evaluations needed for study participation
          6. Volunteer is cognitively impaired
          7. Volunteer and or the volunteer s parents/legal guardian is unable or unwilling to give
             informed consent/assent
          8. Volunteer has functional limitations
          9. Volunteer has joint or muscle problems
        Note that the following screening activities may be performed to determine subject
        eligibility:
          -  Email, written, or telephone communications with prospective subjects
          -  Review of existing medical records
          -  Review of existing imaging studies
          -  Review of existing photographs or videos
          -  Review of existing pathology specimens/reports from a specimen obtained for diagnostic
             purposes

Study details

Dermatomyositis, Polymyositis, Inclusion Body Myositis

NCT00017914

National Institute of Environmental Health Sciences (NIEHS)

14 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.